John Koconis - 14 Sep 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
CEO & President, Director
Signature
/s/ Joseph Lucchese, Power of Attorney
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
4
Filing time
16 Sep 2021, 16:06:38 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +890,000 $0.000000 890,000 14 Sep 2021 Common Stock, par value $0.001 per share 890,000 $0.8925 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest in equal 36 monthly installments beginning on October 14, 2021, as long as the reporting person remains continuously employed through each vesting date.